Cancers rarely are deadly unless they evolve the ability to grow beyond the tissues in which they first arise.

Veterans Affairs hospitals screen elderly men with limited life expectancies for prostate cancer at surprisingly high rates, even though guidelines recommend against such screening, according to a study led by a physician at the UCSF-affiliated San Francisco VA Medical Center (SFVAMC).

A new UCSF analysis of tobacco industry documents shows that Philip Morris USA manipulated data on the effects of additives in cigarettes, including menthol, obscuring actual toxicity levels and increasing the risk of heart, cancer and other diseases for smokers.

A cancer drug company founded by UCSF Professor Kevan Shokat, PhD, has been acquired by Japan-based Takeda Pharmaceuticals in an effort to add two novel drug projects to Takeda’s pipeline of potential oncology therapies.

Peter Walter, PhD, a professor in the Biochemistry and Biophysics Department within the School of Medicine at the University of California, San Francisco has been awarded the 2012 Paul Ehrlich and Ludwig Darmstaedter Prize for his “outstanding research achievements in the field of cell biology.”

As a woman ages, her chances of being diagnosed with a lower-risk breast tumor increase, according to a novel study led by UCSF which found that for women over 50, a substantial number of cancers detected by mammograms have good prognoses.